梅特福明和欧洲人口中慢性病的风险因素基于孟德尔随机化
Xiaopei Liu1, Xingyao Li2, Peng An2
1Department of Traditional Chinese Medicine, Huangling Hospital of Traditional Chinese Medicine, Yan'an, Shaanxi, China.
Renal failure
|April 28, 2025
概括
根据孟德尔的随机化,甲福明可能会增加慢性病 (CKD) 的风险. 研究人员确定了与CKD相关的特定基因,敦促对脏患者处方甲福林时谨慎行事.
科学领域:
- 药物基因组学 药物基因组学
- 腎臟病學 (nephrology) 是一種醫學.
- 遗传流行病学遗传流行病学
背景情况:
- 甲胺是2型糖尿病的主要治疗方法.
- 人们对甲福明在慢性病 (CKD) 中的安全性存在担忧,原因是乳酸和对功能的影响等潜在风险.
- 甲胺和CKD之间的因果关系需要进一步调查.
研究的目的:
- 通过使用遗传关联方法,调查甲福明使用与慢性病 (CKD) 之间的潜在因果关系.
- 确定可能调解甲胺对CKD风险的影响的特定基因.
主要方法:
- 采用孟德尔随机化 (MR) 技术,包括MR-Egger,加权中位数和逆方差加权 (IVW).
- 利用基于总结数据的门德尔随机化 (SMR) 分析,使用来自英国生物银行和FinnGen.的eQTL和CKD数据.
- 对甲福明的药物标数据与遗传数据交叉,以识别相关基因.
主要成果:
- 核磁共振分析表明,与甲福明相关的CKD风险可能增加 (IVW模型:OR = 144.67,p < 0.01).
- 高赔率比率 (OR) 需要进一步验证.
- 在SMR分析中,ANPEP,STK11,ACACB和RPS6KB被确定为与CKD风险显著相关的基因.
结论:
- 甲胺可能与慢性病的风险增加有关.
- 特定的基因 (ANPEP,STK11,ACACB,RPS6KB) 与CKD风险有关.
- 在对患有功能障碍的患者处方甲福明时,建议采取临床谨慎,等待进一步的研究.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
133
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
133
01:17Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
01:11Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
01:33Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
121
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
121
01:45Kidney Structure
66.8K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
66.8K